Literature DB >> 11108513

A 15-year follow-up of a boy with pyridoxine (vitamin B6)-dependent seizures with autism, breath holding, and severe mental retardation.

L Burd1, A Stenehjem, L A Franceschini, J Kerbeshian.   

Abstract

Pyridoxine (vitamin B6) (2q31) dependency is a rare autosomal-recessive disorder that causes a severe seizure disorder of prenatal or neonatal onset. The abnormality appears to inhibit the binding of vitamin B6 to the enzyme glutamic acid decarboxylase-1, which is needed for the biosynthesis of gamma-aminobutyric acid (GABA). Most patients with pyridoxine-dependent seizures require lifelong treatment with pyridoxine. The full range of associated symptomatology is unknown since fewer than 100 cases have been reported. A majority of cases are mentally retarded. We report a 15-year-old boy with pyridoxine-dependent seizures, nonpyridoxine-dependent seizures, severe mental retardation, autistic disorder, aerophagia, breath holding, and self-injury. This complex outcome should alert clinicians to the wide range of neuropsychiatric outcomes associated with this disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108513     DOI: 10.1177/088307380001501111

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

1.  Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder.

Authors:  Timothy M DeLorey; Peyman Sahbaie; Ezzat Hashemi; Gregg E Homanics; J David Clark
Journal:  Behav Brain Res       Date:  2007-09-14       Impact factor: 3.332

2.  First cases of pyridoxine-dependent epilepsy in Bulgaria: novel mutation in the ALDH7A1 gene.

Authors:  Savina Tincheva; Tihomir Todorov; Albena Todorova; Ralica Georgieva; Dimitar Stamatov; Iglika Yordanova; Tanya Kadiyska; Bilyana Georgieva; Maria Bojidarova; Genoveva Tacheva; Ivan Litvinenko; Vanyo Mitev
Journal:  Neurol Sci       Date:  2015-08-01       Impact factor: 3.307

Review 3.  Pediatric neurotransmitter diseases.

Authors:  Phillip L Pearl; Denise D Wallis; K Michael Gibson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

Review 4.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

5.  Potential identification of vitamin B6 responsiveness in autism spectrum disorder utilizing phenotype variables and machine learning methods.

Authors:  Taku Obara; Mami Ishikuro; Gen Tamiya; Masao Ueki; Chizuru Yamanaka; Satoshi Mizuno; Masahiro Kikuya; Hirohito Metoki; Hiroko Matsubara; Masato Nagai; Tomoko Kobayashi; Machiko Kamiyama; Mikako Watanabe; Kazuhiko Kakuta; Minami Ouchi; Aki Kurihara; Naru Fukuchi; Akihiro Yasuhara; Masumi Inagaki; Makiko Kaga; Shigeo Kure; Shinichi Kuriyama
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.